1. Home
  2. GPRE vs FTRE Comparison

GPRE vs FTRE Comparison

Compare GPRE & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

HOLD

Current Price

$15.98

Market Cap

812.2M

Sector

Industrials

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.12

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRE
FTRE
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.2M
829.3M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
GPRE
FTRE
Price
$15.98
$9.12
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$11.31
$14.17
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,091,680,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$11.85
$3.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$3.14
$3.97
52 Week High
$17.94
$18.67

Technical Indicators

Market Signals
Indicator
GPRE
FTRE
Relative Strength Index (RSI) 53.06 41.04
Support Level $9.25 $8.80
Resistance Level $16.80 $11.22
Average True Range (ATR) 0.97 0.65
MACD -0.20 0.11
Stochastic Oscillator 41.10 30.71

Price Performance

Historical Comparison
GPRE
FTRE

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: